Found: 8
Select item for more details and to access through your institution.
Why Has the Use of Health Economic Evaluation in Japan Lagged Behind that in Other Developed Countries?
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 1, doi. 10.2165/00019053-200220002-00001
- By:
- Publication type:
- Article
Information Barriers to the Implementation of Economic Evaluations in Japan.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 9, doi. 10.2165/00019053-200220002-00002
- By:
- Publication type:
- Article
The Development and Use of Quality-of-Life Measures to Evaluate Health Outcomes in Japan.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 17, doi. 10.2165/00019053-200220002-00003
- By:
- Publication type:
- Article
Agenda for the Future.
- Published in:
- PharmacoEconomics, 2002, v. 20, n. 10, p. 25, doi. 10.2165/00019053-200220002-00004
- By:
- Publication type:
- Article
Cost of illness of Crohn's disease.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Economic analysis of filgrastim use for patients with acute myeloid leukaemia in the UK: a comparison of collection methods of resource use data.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.
- Published in:
- 2002
- By:
- Publication type:
- journal article